CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic Stroke (CERBERUS)
Acute Ischemic Stroke
About this trial
This is an interventional treatment trial for Acute Ischemic Stroke focused on measuring Acute Ischemic Stroke, blood-brain barrier, cerebrolysin
Eligibility Criteria
Inclusion Criteria: acute ischemic stroke patients informed consent Exclusion Criteria: no informed consent primary or metastatic brain tumor brain abscess encephalitis localized inflammation sepsis autoimmune diseases of central or peripheral nervous system Cerebrolysin hypersensitivity / allergy epilepsy severe kidney disease
Sites / Locations
- University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Experimental
No Intervention
Thrombolysis and/or mechanical thrombectomy
Cerebrolysin
No reperfusion therapy / no cerebrolysin
patients included for reperfusion therapy (intravenous thrombolysis and/or mechanical thrombectomy - comparator
patients included for reperfusion therapy (intravenous thrombolysis and/or mechanical thrombectomy and treated with Cerebrolysin
patients not referred to reperfusion therapy nor Cerebrolysin